Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
International Journal of Radiation Oncology, Biology, Physics|July 19, 2014
Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapyRobert B Den, Felix Y Feng, Timothy N Showalter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancerMichael J Morris, Chaitanya R Divgi, Neeta Pandit-Taskar, et al.
European Urology|August 7, 2025
Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate CancerSusan Halabi, Siyuan Guo, Bin Luo, et al.
JAMA Oncology|August 22, 2024
Olaparib Without Androgen Deprivation for High-Risk Biochemically Recurrent Prostate Cancer Following Prostatectomy: A Nonrandomized Controlled TrialCatherine H Marshall, Benjamin A Teply, Jiayun Lu, et al.
European Urology|January 12, 2020
Veterans Affairs Cooperative Studies Program Study #553: Chemotherapy After Prostatectomy for High-risk Prostate Carcinoma: A Phase III Randomized StudyDaniel W Lin, Mei-Chiung Shih, William Aronson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2026
Carboplatin, Cabazitaxel and Abiraterone in High-Volume Metastatic Castration-Sensitive Prostate Cancer: The CASCARA Phase 2 StudyEmmanuel S Antonarakis, Qing Cao, Victoria Catharine, et al.
Prostate Cancer and Prostatic Diseases|November 14, 2019
Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomyJoseph Marascio, Daniel E Spratt, Jingbin Zhang, et al.
European Urology Oncology|November 14, 2018
Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 TrialFern Anari, John O'Neill, Woonyoung Choi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2020
CD8<sup>+</sup> T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated AntigensNeal D Shore, Matthew P Morrow, Trevor McMullan, et al.
Urology Case Reports|October 8, 2016
Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case ReportHyun Kim, Mohammed Alshalalfa, Jean Hoffman-Censits, et al.
Pageof 6